Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic
The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medic...
Gespeichert in:
| Veröffentlicht in: | Journal of the American Pharmacists Association 2020-11, Vol.60 (6), p.e76-e79 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e79 |
|---|---|
| container_issue | 6 |
| container_start_page | e76 |
| container_title | Journal of the American Pharmacists Association |
| container_volume | 60 |
| creator | Pritchard, Roger Iain Huff, Jamie Scheinberg, Nataliya |
| description | The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services. |
| doi_str_mv | 10.1016/j.japh.2020.06.004 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7294253</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1544319120302703</els_id><sourcerecordid>2418730801</sourcerecordid><originalsourceid>FETCH-LOGICAL-c455t-b76358884e3b16108027b8788dc36799f7ea6ed7b98e7158f9e2a4d0f8c796493</originalsourceid><addsrcrecordid>eNp9kU1r3DAQhkVpadK0f6CHomMvdiVL1geUQtm2yUIglyangpCl8VqLvyrJC_n38bJJaC85zcC8887LPAh9pKSkhIov-3Jv566sSEVKIkpC-Ct0TmvOC8Zr8vqpp5qeoXcp7QmppNDqLTpjVa2ZYOwc_dkOs3UZTy2OsFt6m6d4j11nxx0kPI147mwcrAspFx76cIAIHmfooQPb5w77JYZxh3MHeHNzt_1RUI1nO3oYgnuP3rS2T_DhsV6g218_f2-uiuuby-3m-3XheF3nopGC1UopDqyhghK15myUVMo7JqTWrQQrwMtGK5C0Vq2GynJPWuWkFlyzC_Tt5DsvzQDewZij7c0cw2DjvZlsMP9PxtCZ3XQwstK8qtlq8PnRIE5_F0jZDCE56Hs7wrQkU3GqJFuD0VVanaQuTilFaJ_PUGKOWMzeHLGYIxZDhFmxrEuf_g34vPLEYRV8PQlgfdMhQDTJBRgd-BDBZeOn8JL_Aw_-nvg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2418730801</pqid></control><display><type>article</type><title>Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Pritchard, Roger Iain ; Huff, Jamie ; Scheinberg, Nataliya</creator><creatorcontrib>Pritchard, Roger Iain ; Huff, Jamie ; Scheinberg, Nataliya</creatorcontrib><description>The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services.</description><identifier>ISSN: 1544-3191</identifier><identifier>EISSN: 1544-3450</identifier><identifier>DOI: 10.1016/j.japh.2020.06.004</identifier><identifier>PMID: 32593633</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Centers for Medicare and Medicaid Services, U.S ; COVID-19 - drug therapy ; COVID-19 - epidemiology ; Government Regulation ; Humans ; Pharmacists - economics ; Pharmacists - legislation & jurisprudence ; Pharmacists - organization & administration ; Professional Role ; Reimbursement Mechanisms - legislation & jurisprudence ; SARS-CoV-2 ; Science and Practice ; Telemedicine - economics ; Telemedicine - legislation & jurisprudence ; Telemedicine - organization & administration ; United States - epidemiology</subject><ispartof>Journal of the American Pharmacists Association, 2020-11, Vol.60 (6), p.e76-e79</ispartof><rights>2020 American Pharmacists Association</rights><rights>Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.</rights><rights>2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved. 2020 American Pharmacists Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c455t-b76358884e3b16108027b8788dc36799f7ea6ed7b98e7158f9e2a4d0f8c796493</citedby><cites>FETCH-LOGICAL-c455t-b76358884e3b16108027b8788dc36799f7ea6ed7b98e7158f9e2a4d0f8c796493</cites><orcidid>0000-0002-6828-907X ; 0000-0003-4037-1618</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32593633$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pritchard, Roger Iain</creatorcontrib><creatorcontrib>Huff, Jamie</creatorcontrib><creatorcontrib>Scheinberg, Nataliya</creatorcontrib><title>Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic</title><title>Journal of the American Pharmacists Association</title><addtitle>J Am Pharm Assoc (2003)</addtitle><description>The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services.</description><subject>Centers for Medicare and Medicaid Services, U.S</subject><subject>COVID-19 - drug therapy</subject><subject>COVID-19 - epidemiology</subject><subject>Government Regulation</subject><subject>Humans</subject><subject>Pharmacists - economics</subject><subject>Pharmacists - legislation & jurisprudence</subject><subject>Pharmacists - organization & administration</subject><subject>Professional Role</subject><subject>Reimbursement Mechanisms - legislation & jurisprudence</subject><subject>SARS-CoV-2</subject><subject>Science and Practice</subject><subject>Telemedicine - economics</subject><subject>Telemedicine - legislation & jurisprudence</subject><subject>Telemedicine - organization & administration</subject><subject>United States - epidemiology</subject><issn>1544-3191</issn><issn>1544-3450</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1r3DAQhkVpadK0f6CHomMvdiVL1geUQtm2yUIglyangpCl8VqLvyrJC_n38bJJaC85zcC8887LPAh9pKSkhIov-3Jv566sSEVKIkpC-Ct0TmvOC8Zr8vqpp5qeoXcp7QmppNDqLTpjVa2ZYOwc_dkOs3UZTy2OsFt6m6d4j11nxx0kPI147mwcrAspFx76cIAIHmfooQPb5w77JYZxh3MHeHNzt_1RUI1nO3oYgnuP3rS2T_DhsV6g218_f2-uiuuby-3m-3XheF3nopGC1UopDqyhghK15myUVMo7JqTWrQQrwMtGK5C0Vq2GynJPWuWkFlyzC_Tt5DsvzQDewZij7c0cw2DjvZlsMP9PxtCZ3XQwstK8qtlq8PnRIE5_F0jZDCE56Hs7wrQkU3GqJFuD0VVanaQuTilFaJ_PUGKOWMzeHLGYIxZDhFmxrEuf_g34vPLEYRV8PQlgfdMhQDTJBRgd-BDBZeOn8JL_Aw_-nvg</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>Pritchard, Roger Iain</creator><creator>Huff, Jamie</creator><creator>Scheinberg, Nataliya</creator><general>Elsevier Inc</general><general>American Pharmacists Association®. Published by Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6828-907X</orcidid><orcidid>https://orcid.org/0000-0003-4037-1618</orcidid></search><sort><creationdate>20201101</creationdate><title>Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic</title><author>Pritchard, Roger Iain ; Huff, Jamie ; Scheinberg, Nataliya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c455t-b76358884e3b16108027b8788dc36799f7ea6ed7b98e7158f9e2a4d0f8c796493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Centers for Medicare and Medicaid Services, U.S</topic><topic>COVID-19 - drug therapy</topic><topic>COVID-19 - epidemiology</topic><topic>Government Regulation</topic><topic>Humans</topic><topic>Pharmacists - economics</topic><topic>Pharmacists - legislation & jurisprudence</topic><topic>Pharmacists - organization & administration</topic><topic>Professional Role</topic><topic>Reimbursement Mechanisms - legislation & jurisprudence</topic><topic>SARS-CoV-2</topic><topic>Science and Practice</topic><topic>Telemedicine - economics</topic><topic>Telemedicine - legislation & jurisprudence</topic><topic>Telemedicine - organization & administration</topic><topic>United States - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pritchard, Roger Iain</creatorcontrib><creatorcontrib>Huff, Jamie</creatorcontrib><creatorcontrib>Scheinberg, Nataliya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the American Pharmacists Association</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pritchard, Roger Iain</au><au>Huff, Jamie</au><au>Scheinberg, Nataliya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic</atitle><jtitle>Journal of the American Pharmacists Association</jtitle><addtitle>J Am Pharm Assoc (2003)</addtitle><date>2020-11-01</date><risdate>2020</risdate><volume>60</volume><issue>6</issue><spage>e76</spage><epage>e79</epage><pages>e76-e79</pages><issn>1544-3191</issn><eissn>1544-3450</eissn><abstract>The 2020 coronavirus disease pandemic in the United States has created a dramatic need for the rapid implementation of telehealth services in areas of the country where telehealth is limited in scope. This implementation would not be possible without changes in how the Centers for Medicare and Medicaid Services provide reimbursement for these services. Reimbursement options remain open to pharmacists, but depend on local regulation or the ability to alter practice at the site. Though pharmacists provide high-quality direct patient care, they are excluded from seeking compensation for providing this care, even as the nation expands the telehealth model. This overview shows that despite changes in telehealth service compensation for health care providers, pharmacists remain unable to seek appropriate compensation for their direct patient care services.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32593633</pmid><doi>10.1016/j.japh.2020.06.004</doi><orcidid>https://orcid.org/0000-0002-6828-907X</orcidid><orcidid>https://orcid.org/0000-0003-4037-1618</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1544-3191 |
| ispartof | Journal of the American Pharmacists Association, 2020-11, Vol.60 (6), p.e76-e79 |
| issn | 1544-3191 1544-3450 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7294253 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Centers for Medicare and Medicaid Services, U.S COVID-19 - drug therapy COVID-19 - epidemiology Government Regulation Humans Pharmacists - economics Pharmacists - legislation & jurisprudence Pharmacists - organization & administration Professional Role Reimbursement Mechanisms - legislation & jurisprudence SARS-CoV-2 Science and Practice Telemedicine - economics Telemedicine - legislation & jurisprudence Telemedicine - organization & administration United States - epidemiology |
| title | Impact of regulatory changes on pharmacist-delivered telehealth during the COVID-19 pandemic |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T16%3A06%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20regulatory%20changes%20on%20pharmacist-delivered%20telehealth%20during%20the%20COVID-19%20pandemic&rft.jtitle=Journal%20of%20the%20American%20Pharmacists%20Association&rft.au=Pritchard,%20Roger%20Iain&rft.date=2020-11-01&rft.volume=60&rft.issue=6&rft.spage=e76&rft.epage=e79&rft.pages=e76-e79&rft.issn=1544-3191&rft.eissn=1544-3450&rft_id=info:doi/10.1016/j.japh.2020.06.004&rft_dat=%3Cproquest_pubme%3E2418730801%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2418730801&rft_id=info:pmid/32593633&rft_els_id=S1544319120302703&rfr_iscdi=true |